Synthesis and DNase I inhibitory properties of new benzocyclobutane-2,5-diones
Authorized Users Only
2019
Authors
Bondžić, Bojan
Džambaski, Zdravko

Kolarević, Ana
Đorđević, Aleksandra
Anderluh, Marko
Šmelcerović, Andrija
Article (Published version)

Newlands Press
Metadata
Show full item recordAbstract
Eight new benzocyclobutane-2,5-diones (1a–1h) were synthesized, and their inhibitory properties
against bovine pancreatic DNase I were examined in vitro. Methods & results: Compounds 1a–1h
were synthesized using photocycloaddition of duroquinone with various phenyl-substituted ethylenes
in the presence of 18W compact fluorescent lamp (visible light). Two compounds, 1,3,4,6-tetramethyl-7-
phenylbicyclo[4.2.0]oct-3-ene-2,5-dione (1a) and 1,3,4,6-tetramethyl-7-p-tolylbicyclo[4.2.0]oct-3-ene-2,5-
dione (1b) inhibited DNase I in a noncompetitive manner with IC50 values below 150 μM and showed to
be more potent DNase I inhibitors than crystal violet, used as a positive control. In order to analyze potential
binding sites for the studied compounds with DNase I, molecular docking study was performed.
Conclusion: The studied benzocyclobutane-2,5-diones offer a good starting point for a design of new
DNase I inhibitors.
Keywords:
benzocyclobutane-2,5-diones / DNase I inhibition / Lineweaver–Burk plot / molecular docking / synthesisSource:
Future Medicinal Chemistry, 2019, 11, 18, 2415-Publisher:
- Future Medicine Ltd.
Funding / projects:
- Experimental and theoretical study of reactivity and biological activity of stereodefined thiazolidines and their synthetic analogues (RS-172020)
- Obtaining, physicochemical characterization, analysis and biological activity of pharmacologically active compounds (RS-172044)
- Faculty of Medicine of the University of Nis (internal project no. 4)
- Slovenian Research Agency (grant no. P1-0208)
DOI: 10.4155/fmc-2019-0032
ISSN: 1756-8919
PubMed: 31526044
WoS: 000498836900006
Scopus: 2-s2.0-85072993481
Collections
Institution/Community
IHTMTY - JOUR AU - Bondžić, Bojan AU - Džambaski, Zdravko AU - Kolarević, Ana AU - Đorđević, Aleksandra AU - Anderluh, Marko AU - Šmelcerović, Andrija PY - 2019 UR - https://cer.ihtm.bg.ac.rs/handle/123456789/3957 AB - Eight new benzocyclobutane-2,5-diones (1a–1h) were synthesized, and their inhibitory properties against bovine pancreatic DNase I were examined in vitro. Methods & results: Compounds 1a–1h were synthesized using photocycloaddition of duroquinone with various phenyl-substituted ethylenes in the presence of 18W compact fluorescent lamp (visible light). Two compounds, 1,3,4,6-tetramethyl-7- phenylbicyclo[4.2.0]oct-3-ene-2,5-dione (1a) and 1,3,4,6-tetramethyl-7-p-tolylbicyclo[4.2.0]oct-3-ene-2,5- dione (1b) inhibited DNase I in a noncompetitive manner with IC50 values below 150 μM and showed to be more potent DNase I inhibitors than crystal violet, used as a positive control. In order to analyze potential binding sites for the studied compounds with DNase I, molecular docking study was performed. Conclusion: The studied benzocyclobutane-2,5-diones offer a good starting point for a design of new DNase I inhibitors. PB - Future Medicine Ltd. T2 - Future Medicinal Chemistry T1 - Synthesis and DNase I inhibitory properties of new benzocyclobutane-2,5-diones VL - 11 VL - 2426 IS - 18 SP - 2415 DO - 10.4155/fmc-2019-0032 ER -
@article{ author = "Bondžić, Bojan and Džambaski, Zdravko and Kolarević, Ana and Đorđević, Aleksandra and Anderluh, Marko and Šmelcerović, Andrija", year = "2019", abstract = "Eight new benzocyclobutane-2,5-diones (1a–1h) were synthesized, and their inhibitory properties against bovine pancreatic DNase I were examined in vitro. Methods & results: Compounds 1a–1h were synthesized using photocycloaddition of duroquinone with various phenyl-substituted ethylenes in the presence of 18W compact fluorescent lamp (visible light). Two compounds, 1,3,4,6-tetramethyl-7- phenylbicyclo[4.2.0]oct-3-ene-2,5-dione (1a) and 1,3,4,6-tetramethyl-7-p-tolylbicyclo[4.2.0]oct-3-ene-2,5- dione (1b) inhibited DNase I in a noncompetitive manner with IC50 values below 150 μM and showed to be more potent DNase I inhibitors than crystal violet, used as a positive control. In order to analyze potential binding sites for the studied compounds with DNase I, molecular docking study was performed. Conclusion: The studied benzocyclobutane-2,5-diones offer a good starting point for a design of new DNase I inhibitors.", publisher = "Future Medicine Ltd.", journal = "Future Medicinal Chemistry", title = "Synthesis and DNase I inhibitory properties of new benzocyclobutane-2,5-diones", volume = "11, 2426", number = "18", pages = "2415", doi = "10.4155/fmc-2019-0032" }
Bondžić, B., Džambaski, Z., Kolarević, A., Đorđević, A., Anderluh, M.,& Šmelcerović, A.. (2019). Synthesis and DNase I inhibitory properties of new benzocyclobutane-2,5-diones. in Future Medicinal Chemistry Future Medicine Ltd.., 11(18), 2415. https://doi.org/10.4155/fmc-2019-0032
Bondžić B, Džambaski Z, Kolarević A, Đorđević A, Anderluh M, Šmelcerović A. Synthesis and DNase I inhibitory properties of new benzocyclobutane-2,5-diones. in Future Medicinal Chemistry. 2019;11(18):2415. doi:10.4155/fmc-2019-0032 .
Bondžić, Bojan, Džambaski, Zdravko, Kolarević, Ana, Đorđević, Aleksandra, Anderluh, Marko, Šmelcerović, Andrija, "Synthesis and DNase I inhibitory properties of new benzocyclobutane-2,5-diones" in Future Medicinal Chemistry, 11, no. 18 (2019):2415, https://doi.org/10.4155/fmc-2019-0032 . .